LOS ANGELES CAPITAL MANAGEMENT LLC - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 118 filers reported holding ANIKA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$259,330
+5.0%
13,920
+46.4%
0.00%0.0%
Q2 2023$247,070
-11.4%
9,510
-2.1%
0.00%0.0%
Q1 2023$278,871
-12.0%
9,710
-9.3%
0.00%
-50.0%
Q4 2022$317,016
-44.4%
10,710
-55.3%
0.00%
-33.3%
Q3 2022$570,000
+13.5%
23,960
+6.6%
0.00%
+50.0%
Q2 2022$502,000
-14.5%
22,470
-3.9%
0.00%0.0%
Q1 2022$587,000
-51.4%
23,385
-30.6%
0.00%
-60.0%
Q4 2021$1,208,000
-24.5%
33,717
-10.2%
0.01%
-28.6%
Q3 2021$1,599,000
-8.2%
37,562
-6.6%
0.01%
-12.5%
Q2 2021$1,741,000
-19.3%
40,222
-23.9%
0.01%
-20.0%
Q1 2021$2,157,000
-30.6%
52,877
-23.0%
0.01%
-23.1%
Q4 2020$3,109,000
+2.5%
68,688
-19.8%
0.01%
-7.1%
Q3 2020$3,032,000
-23.5%
85,680
-18.4%
0.01%
-26.3%
Q2 2020$3,961,000
+40.9%
104,971
+7.9%
0.02%
+5.6%
Q1 2020$2,812,000
+622.9%
97,276
+1197.5%
0.02%
+800.0%
Q4 2019$389,000
+9.6%
7,497
+15.9%
0.00%0.0%
Q3 2019$355,000
-2.2%
6,467
-46.2%
0.00%0.0%
Q1 2019$363,000
-33.6%
12,016
-26.2%
0.00%
-33.3%
Q4 2018$547,000
-20.4%
16,2860.0%0.00%
-25.0%
Q3 2018$687,000
-8.3%
16,286
-30.4%
0.00%0.0%
Q2 2018$749,000
-35.9%
23,395
-0.4%
0.00%
-42.9%
Q1 2018$1,168,000
-34.1%
23,495
-28.5%
0.01%
-30.0%
Q4 2017$1,773,000
+38.5%
32,880
+48.9%
0.01%
+42.9%
Q3 2017$1,280,000
+28.5%
22,076
+9.4%
0.01%
+16.7%
Q2 2017$996,000
+14.1%
20,186
+0.5%
0.01%0.0%
Q1 2017$873,000
-27.8%
20,086
-18.7%
0.01%
-33.3%
Q4 2016$1,209,000
+52.3%
24,697
+48.8%
0.01%
+28.6%
Q3 2016$794,000
-10.8%
16,5970.0%0.01%
-12.5%
Q2 2016$890,000
-10.6%
16,597
-25.5%
0.01%
-11.1%
Q1 2016$996,000
-5.2%
22,265
-19.2%
0.01%
-10.0%
Q4 2015$1,051,000
+63.5%
27,545
+36.3%
0.01%
+66.7%
Q3 2015$643,000
-3.6%
20,2050.0%0.01%0.0%
Q2 2015$667,000
-16.0%
20,205
+4.8%
0.01%
-14.3%
Q1 2015$794,000
-4.0%
19,285
-5.0%
0.01%
-12.5%
Q4 2014$827,000
+77.1%
20,295
+59.3%
0.01%
+33.3%
Q3 2014$467,00012,7400.01%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 44,875$2,031,0002.14%
Parian Global Management LP 102,705$4,648,0001.16%
CAPITAL MANAGEMENT CORP /VA 93,035$4,211,0001.15%
Avidity Partners Management LP 731,000$33,085,0001.07%
Sio Capital Management, LLC 65,382$2,959,0000.61%
DIKER MANAGEMENT LLC 21,835$988,0000.50%
Archon Capital Management LLC 48,925$2,214,0000.38%
Caption Management, LLC 362,800$16,420,0000.37%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,546,260$69,984,0000.20%
Boston Trust Walden Corp 378,167$17,116,0000.18%
View complete list of ANIKA THERAPEUTICS INC shareholders